Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 11, 2014, Pages 2979-2983

  Chowdhary, Anuradha ^a   Sharma, Cheshta ^a   van den Boom, Mara ^b   Yntema, Jan Bart ^b,c   Hagen, Ferry ^b,c   Verweij, Paul E ^c   Meis, Jacques F ^b,c  

^a UNIVERSITY OF DELHI   (India)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Africa; Azole resistant A. fumigatus; Microsatellite typing; Resistance mechanisms

Indexed keywords

ISAVUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; PYRROLE DERIVATIVE;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; CROSS RESISTANCE; FUNGUS ISOLATION; FUNGUS MUTATION; GENOTYPE; MICROSATELLITE MARKER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SOIL; TANZANIA; DRUG EFFECTS; ENVIRONMENT; GENETICS; HUMAN; ISOLATION AND PURIFICATION;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; AZOLES; DRUG RESISTANCE, FUNGAL; ENVIRONMENT; HUMANS; TANZANIA;

EID: 84923249087     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku259     Document Type: Article

References (22)

1. Howard SJ, Cerar D, Anderson MJ et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15:1068-76.
2. van der Linden JW, Snelders E, Kampinga GA et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis 2011; 17:1846-54.
3. Alanio A, Sitterlé E, Liance M et al. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J Antimicrob Chemother 2011; 66:371-4.
4. Chowdhary A, Kathuria S, Randhawa HS et al. Isolation of multipletriazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 2012; 67:362-6.
5. Seyedmousavi S, Hashemi SJ, Zibafar E et al. Azole-resistant Aspergillus fumigatus, Iran. Emerg Infect Dis 2013; 19:832-4.
6. van der Linden JWM, Arendrup MC, Verweij PE et al. Prospective international surveillance of azole resistance in Aspergillus fumigatus: SCARE-Network. In: Abstracts of the Fifty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2011. Abstract M-490. American Society for Microbiology, Washington, DC, USA.
7. Lockhart SR, Frade JP, Etienne KA et al. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 2011; 55:4465-8.
8. Baddley JW, Marr KA, Andes DR et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47:3271-5.
9. Tashiro M, Izumikawa K, Minematsu A et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother 2012; 56:584-7.
10. Badali H, Vaezi A, Haghani I et al. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses 2013; 56:659-63.
11. Chowdhary A, Kathuria S, Xu J et al. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS One 2012; 7: e52871.
12. Snelders E, van der Lee HA, Kuijpers J et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219.
13. Chowdhary A, Kathuria S, Xu J et al. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 2013; 9: e1003633.
14. Snelders E, Camps SM, Karawajczyk A et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One 2012; 7: e31801.
15. van der Linden JW, Camps SM, Kampinga GA et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 2013; 57:513-20.
16. Vermeulen E, Maertens J, Schoemans H et al. Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill 2012; 17: pii1/420326.
17. Chowdhary A, Sharma C, Kathuria S et al. Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J Antimicrob Chemother 2014; 69:555-7.
18. Fischer J, van Koningsbruggen-Rietschel S, Rietschel E et al. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J Antimicrob Chemother 2014; 69:1533-6.
19. Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 2011; 89:864-72.
20. Pohl C, Jugheli L, Haraka F et al. Pulmonary aspergilloma: a treatment challenge in sub-Saharan Africa. PLoS Negl Trop Dis 2013; 7: e2352.
21. Ahmad S, Khan Z, Hagen F et al. Simple, low-cost molecular assays for TR34/L98H mutations in the cyp51A gene for rapid detection of triazoleresistant Aspergillus fumigatus isolates. J Clin Microbiol 2014; 52:2223-7.
22. de Valk HA, Meis JF, de Pauw BE et al. Comparison of two highly discriminatory molecular fingerprinting assays for analysis of multiple Aspergillus fumigatus isolates from patients with invasive aspergillosis. J Clin Microbiol 2007; 45:1415-9.